Dr. Subramaniam joins UBC as Gobind Khorana Canada Excellence Research Chair in Precision Cancer Drug Design

Date Posted: 
2019-04-18
Dr. Subramaniam

April 17, 2019 - Dr. Sriram Subramaniam has joined the University of British Columbia (UBC) as the Gobind Khorana Canada Excellence Research Chair in Precision Cancer Drug Design.

Dr. Subramaniam is recognized as a global leader in the emerging field of cryo-electron microscopy, or cryo-EM, a technology that has sparked a revolution in imaging of protein complexes. He is appointed both in the Department of Urologic Sciences and in Biochemistry and Molecular biology at UBC and is linked to the precision cancer drug design program at the Vancouver Prostate Centre.

VGH & UBC Hospital Foundation today announced an $18 million gift from Aqueduct Foundation on behalf of an anonymous donor support the design of precise, targeted and cost-effective drugs for cancer in work led by Dr. Subramaniam in close partnership with the Vancouver Prostate Centre and other research centres.

Read more about Dr. Subramaniam and the transformational donation at the links below:
Scientists join UBC as new Canada Excellence Research Chairs
Global leader in precision cancer drug design joins the faculty of medicine
Transforming cancer treatment in BC
Changing the future of cancer drug design: A foundational relationship

 

 

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Fathers Day Walk Run 2019

Raymond James Father's Day Walk Run Fundraiser, June 16, 2019

The 21st Annual Raymond James Walk Run fundraiser for Prostate Cancer Foundation BC took place on Sunday June 16, 2019 in various locations across BC. The sponsorship page is still accepting donations;  click here to sponsor our Centre's team (opens in new window).

 

Employment

Work at the Vancouver Prostate Centre

Monday, July 8, 2019

Dr. Flannigan to lead clinical trial for scrotal pain treatment

Dr. Flannigan
Monday, June 3, 2019

Benefits Seen With Apalutamide Plus ADT in Metastatic Castration-Sensitive Prostate Cancer

Dr. Chi